Axonal amyloid precursor protein and its fragments undergo somatodendritic endocytosis and processing

Molecular Biology of the Cell

Volumn 26, Issue 2, 2015, Pages 205-217

  Niederst, Emily D ^a,b   Reyna, Sol M ^a   Goldstein, Lawrence S B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; 2-(((3,5-DIFLUOROPHENYL)ACETYL)AMINO)-N-(1-METHYL-2-OXO-5-PHENYL-2,3-DIHYDRO-1H-1,4-BENZODIAZEPIN-3-YL)PROPANAMIDE; BENZODIAZEPINE DERIVATIVE; HYDRAZONE DERIVATIVE; N'-(3,4-DIHYDROXYBENZYLIDENE)-3-HYDROXY-2-NAPHTHAHYDRAZIDE; OLIGOPEPTIDE; OM99-2; PEPTIDE FRAGMENT; PHOTOPROTEIN; SECRETASE;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CELL COMPARTMENTALIZATION; CONTROLLED STUDY; DENDRITE; EMBRYO; EMBRYONIC STEM CELL; ENDOCYTOSIS; HUMAN; HUMAN CELL; MEASUREMENT; MICROFLUIDICS; MOUSE; NERVE FIBER; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN SECRETION; SOMATODENDRITE; ANIMAL; ANTAGONISTS AND INHIBITORS; AXON; C57BL MOUSE; CELL CULTURE; CELL DIFFERENTIATION; CELL LINE; CONFOCAL MICROSCOPY; DRUG EFFECTS; GENETICS; KNOCKOUT MOUSE; METABOLISM; MICROFLUIDIC ANALYSIS; PHYSIOLOGY; SIGNAL TRANSDUCTION;

AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; AXONS; BENZODIAZEPINONES; CELL DIFFERENTIATION; CELL LINE; CELLS, CULTURED; DENDRITES; EMBRYONIC STEM CELLS; ENDOCYTOSIS; HUMANS; HYDRAZONES; LUMINESCENT PROTEINS; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROFLUIDIC ANALYTICAL TECHNIQUES; MICROSCOPY, CONFOCAL; OLIGOPEPTIDES; PEPTIDE FRAGMENTS; SIGNAL TRANSDUCTION;

EID: 84920972904     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E14-06-1049     Document Type: Article

References (61)

1. Abramov E, Dolev I, Fogel H, Ciccotosto GD, Ruff E, Slutsky I (2009). Amyloid-beta as a positive endogenous regulator of release probability at hippocampal synapses. Nat Neurosci 12, 1567-1576.
2. Andersen OM, Reiche J, Schmidt V, Gotthardt M, Spoelgen R, Behlke J, von Armin CA, Breiderhoff T, Jansen P, et al. (2005). Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein. Proc Natl Acad Sci USA 102, 13461-13466.
3. Ascano M, Richmond A, Borden P, Kuruvilla R (2009). Axonal targeting of Trk receptors via transcytosis regulates sensitivity to neurotrophin responses. J Neurosci 29, 11674-11685.
4. Bel C, Oguievetskaia K, Pitaval C, Goutebroze L, Faivre-Sarrailh C (2009). Axonal targeting of Caspr2 in hippocampal neurons via selective somatodendritic endocytosis. J Cell Sci 122, 3403-3413.
5. Bertram L, Lill CM, Tanzi RE (2010). The genetics of Alzheimer disease: back to the future. Neuron 68, 270-281.
6. Brunholz S, Sisodia S, Lorenzo A, Deyts C, Kins S, Morfini G (2012). Axonal transport of APP and the spatial regulation of APP cleavage and function in neuronal cells. Exp Brain Res 217, 353-364.
7. Buytaert-Hoefen KA, Alvarez E, Freed CR (2004). Generation of tyrosine hydroxylase positive neurons from human embryonic stem cells after coculture with cellular substrates and exposure to GDNF. Stem Cells 22, 669-674.
8. Cai D, Leem JY, Greenfield JP, Wang P, Kim BS, Wang R, Lopes KO, Kim SH, Zheng H, Greengard P, et al. (2003). Presenilin-1 regulates intracellular trafficking and cell surface delivery of amyloid precursor protein. J Biol Chem 278, 3446-3454.
9. Carey RM, Balcz BA, Lopez-Coviella I, Slack BE (2005). Inhibition of dynamin-dependent endocytosis increases shedding of the amyloid precursor protein ectodomain and reduces generation of amyloid beta protein. BMC Cell Biol 6, 30-30.
10. Cataldo AM, Petanceska S, Peterhoff CM, Terio NB, Epstein CJ, Villar A, Carlson EJ, Staufenbiel M, Nixon RA (2003). App gene dosage modulates endosomal abnormalities of Alzheimer's disease in a segmental trisomy 16 mouse model of Down syndrome. J Neurosci 23, 6788-6792.
11. Chambers SM, Fasano CA, Papapetrou EP, Tomishima M, Sadelain M, Studer L (2009). Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol 27, 275-280.
12. Cirrito JR, Kang JE, Lee J, Stewart FR, Verges DK, Silverio LM, Bu G, Mennerick S, Holtzman DM (2008). Endocytosis is required for synaptic activity-dependent release of amyloid-beta in vivo. Neuron 58, 42-51.
13. Coleman PD, Yao PJ (2003). Synaptic slaughter in Alzheimer's disease. Neurobiol Aging 24, 1023-1027.
14. Das U, Scott DA, Ganguly A, Koo EH, Tang Y, Roy S (2013). Activity-induced convergence of APP and BACE-1 in acidic microdomains via an endocytosis-dependent pathway. Neuron 79, 447-460.
15. Falzone TL, Stokin GB, Lillo C, Rodrigues EM, Westerman EL, Williams DS, Goldstein LSB (2009). Axonal stress kinase activation and tau misbehavior induced by kinesin-1 transport defects. J Neurosci 29, 5758-5767.
16. Garino C, Tomita T, Pietrancosta N, Laras Y, Rosas R, Herbette G, Maigret B, Quéléver G, Iwatsubo T, Kraus J-L (2006). Naphthyl and coumarinyl biarylpiperazine derivatives as highly potent human beta-secretase inhibitors. Design, synthesis, and enzymatic BACE-1 and cell assays. J Med Chem 49, 4275-4285.
17. Gunawardena S, Goldstein LSB (2001). Disruption of axonal transport and neuronal viability by amyloid precursor protein mutations in Drosophila. Neuron 32, 389-401.
18. Guo Q, Li H, Gaddam SSK, Justice NJ, Robertson CS, Zheng H (2012). Amyloid precursor protein revisited: neuron-specific expression and highly stable nature of soluble derivatives. J Biol Chem 287, 2437-2445.
19. Haass C, Kaether C, Thinakaran G, Sisodia S (2012). Trafficking and proteolytic processing of APP. Cold Spring Harb Perspect Med 2, a006270.
20. Israel MA, Yuan SH, Bardy C, Reyna SM, Mu Y, Herrera C, Hefferan MP, Van Gorp S, Nazor KL, Boscolo FS, et al. (2012). Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells. Nature 482, 216-220.
21. Kaether C, Schmitt S, Willem M, Haass C (2006). Amyloid precursor protein and Notch intracellular domains are generated after transport of their precursors to the cell surface. Traffic 7, 408-415.
22. Kamal A, Almenar-Queralt A, LeBlanc JF, Roberts EA, Goldstein LSB (2001). Kinesin-mediated axonal transport of a membrane compartment containing beta-secretase and presenilin-1 requires APP. Nature 414, 643-648.
23. Kamal A, Stokin GB, Yang Z, Xia C-H, Goldstein LSB (2000). Axonal transport of amyloid precursor protein is mediated by direct binding to the kinesin light chain subunit of kinesin-I. Neuron 28, 449-459.
24. Kawasaki H, Mizuseki K, Nishikawa S, Kaneko S, Kuwana Y, Nakanishi S, Nishikawa S-I, Sasai Y (2000). Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity. Neuron 28, 31-40.
25. Kinoshita A, Fukumoto H, Shah T, Whelan CM, Irizarry MC, Hyman BT (2003). Demonstration by FRET of BACE interaction with the amyloid precursor protein at the cell surface and in early endosomes. J Cell Sci 116, 3339-3346.
26. Koo EH, Sisodia S, Archer DR, Martin LJ, Weidemann A, Beyreuther K, Fischer P, Masters CL, Price DL (1990). Precursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport. Proc Natl Acad Sci 87, 1561-1565.
27. Koo EH, Squazzo SL (1994). Evidence that production and release of amyloid beta-protein involves the endocytic pathway. J Biol Chem 269, 17386-17389.
28. Koo EH, Squazzo SL, Selkoe DJ, Koo CH (1996). Trafficking of cell-surface amyloid beta-protein precursor. I. Secretion, endocytosis and recycling as detected by labeled monoclonal antibody. J Cell Sci 109, 991-998.
29. Lai F, Williams RS (1989). A prospective study of Alzheimer disease in Down syndrome. Arch Neurol 46, 849-853.
30. Lazarov O, Lee M, Peterson DA, Sisodia SS (2002). Evidence that synaptically released beta-Amyloid accumulates as extracellular deposits in the hippocampus of transgenic mice. J Neurosci 22, 9785-9793.
31. Leterrier C, Laine J, Darmon M, Boudin H, Rossier J, Lenkei Z (2006). Constitutive activation drives compartment-selective endocytosis and axonal targeting of type 1 cannabinoid receptors. J Neurosci 26, 3141-3153.
32. Lewczuk P, Esselmann H, Otto M, Maler JM, Henkel AW, Henkel MK, Eikenberg O, Antz C, Krause WR, Reulbach U, et al. (2004). Neurochemical diagnosis of Alzheimer's dementia by CSF A42, A42/A40 ratio and total tau. Neurobiol Aging 25, 273-281.
33. Macia E, Ehrlich M, Massol R, Boucrot E, Brunner C, Kirchhausen T (2006). Dynasore, a cell-permeable inhibitor of dynamin. Dev Cell 10, 839-850.
34. Marzolo M-P, Bu G (2009). Lipoprotein receptors and cholesterol in APP trafficking and proteolytic processing, implications for Alzheimer's disease. Semin Cell Dev Biol 20, 191-200.
35. Meijering E, Jacob M, Sarria JC, Steiner P, Hirling H, Unser M (2004). Design and validation of a tool for neurite tracing and analysis in fluorescence microscopy images. Cytometry A 58, 167-176.
36. Minteer SD (2006). Microfluidic Techniques: Reviews and Protocols, Methods in Molecular Biology 321, New York: Springer.
37. Morel E, Chamoun Z, Lasiecka ZM, Chan RB, Williamson RL, Vetanovetz C, Dall'Armi C, Simoes S, Point Du Jour KS, McCabe BD, et al. (2013). Phosphatidylinositol-3-phosphate regulates sorting and processing of amyloid precursor protein through the endosomal system. Nat Commun 4, 2250.
38. Muresan Z, Muresan V (2007). The amyloid-beta precursor protein is phosphorylated via distinct pathways during differentiation, mitosis, stress, and degeneration. Mol Biol Cell 18, 3835-3844.
39. Muresan V, Varvel NH, Lamb BT, Muresan Z (2009). The cleavage products of amyloid-B precursor protein are sorted to distinct carrier vesicles that are independently transported within neurites. J Neurosci 29, 3565-3578.
40. Nikolaev A, McLaughlin T, O'Leary DDM, Tessier-Lavigne M (2009). APP binds DR6 to trigger axon pruning and neuron death via distinct caspases. Nature 457, 981-989.
41. Park JW, Kim HJ, Byun JH, Ryu HR, Jeon NL (2009). Novel microfluidic platform for culturing neurons: culturing and biochemical analysis of neuronal components. Biotechnol J 4, 1573-1577.
42. Rogaeva E, Meng Y, Lee JH, Gu Y, Kawarai T, Zou F, Katayama T, Baldwin C, Cheng R, Hasegawa H, et al. (2007). The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nat Genet 39, 168-177.
43. Sannerud R, Declerck I, Peric A, Raemaekers T, Menendez G, Zhou L, Veerle B, Coen K, Munck S, De Strooper B, et al. (2011). ADP ribosylation factor 6 (ARF6) controls amyloid precursor protein (APP) processing by mediating the endosomal sorting of BACE1. Proc Natl Acad Sci USA 108, E559-E568.
44. Schneider A, Rajendran L, Honsho M, Gralle M, Donnert G, Wouters F, Hell SW, Simons M (2008). Flotillin-dependent clustering of the amyloid precursor protein regulates its endocytosis and amyloidogenic processing in neurons. J Neurosci 28, 2874-2882.
45. Seiffert D, Bradley JD, Rominger CM, Rominger DH, Yang F, Meredith JE, Wang Q, Roach AH, Thompson LA, Spitz SM, et al. (2000). Presenilin-1 and-2 are molecular targets for g-secretase inhibitors. J Biol Chem 275, 34086-34091.
46. Simons M, Ikonen E, Tienari PJ, Cid-Arregui A, Monning U, Beyreuther K, Dotti CG (1995). Intracellular routing of human amyloid protein precursor: axonal delivery followed by transport to the dendrites. J Neurosci Res 41, 121-128.
47. Sleegers K, Brouwers N, Gijselinck I, Theuns J, Goossens D, Wauters J, Del-Favero J, Cruts M, Duijn CM van, Broeckhoven CV (2006). APP duplication is sufficient to cause early onset Alzheimer's dementia with cerebral amyloid angiopathy. Brain 129, 2977-2983.
48. Stachel SJ, Coburn CA, Steele TG, Jones KG, Loutzenhiser EF, Gregro AR, Rajapaske HA, Lai MT, Crouthamel MC, Xu M, et al. (2004). Structure-based design of potent and selective cell-permeable inhibitors of human beta-secretase (BACE-1). J Med Chem 47, 6447-6450.
49. Stokin GB, Lillo C, Falzone TL, Brusch RG, Rockenstein E, Mount SL, Raman R, Davies P, Masliah E, Williams DS, et al. (2005). Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science 307, 1282-1288.
50. Szpankowski L, Encalada SE, Goldstein LSB (2012). Subpixel colocalization reveals amyloid precursor protein-dependent kinesin-1 and dynein association with axonal vesicles. Proc Natl Acad Sci USA 109, 8582-8587.
51. Tampellini D, Rahmen N, Gallo EF, Huang Z, Dumont M, Capetillo-Zarate E, Ma T, Zheng R, Lu B, Nanus DM, et al. (2009). Synaptic activity reduces intraneuronal Abeta, promotes APP transport to synapses, and protects against Abeta-related synaptic alterations. J Neurosci 29, 9704-9713.
52. Taylor AM, Blurton-Jones M, Rhee SW, Cribbs DH, Cotman CW, Jeon NL (2005). A microfluidic culture platform for CNS axonal injury, regeneration and transport. Nat Methods 2, 599-605.
53. Torroja L, Chu H, Kotovsky I, White K (1999). Neuronal overexpression of APPL, the Drosophila homologue of the amyloid precursor protein (APP), disrupts axonal transport. Curr Biol 9, 489-493.
54. Van Den Heuvel C, Thornton E, Vink R, John TW, Andrew IRM (2007). Traumatic brain injury and Alzheimer's disease: a review. Prog Brain Res 161, 303-316.
55. Wei W, Nguyen LN, Kessels HW, Hagiwara H, Sisodia S, Malinow R (2009). Amyloid beta from axons and dendrites reduces local spine number and plasticity. Nat Neurosci 13, 190-196.
56. Weisz OA, Rodriguez-Boulan E (2009). Apical trafficking in epithelial cells: signals, clusters and motors. J Cell Sci 122, 4253-4266.
57. Wisco D, Anderson ED, Chang MC, Norden C, Boiko T, Folsch H, Winckler B (2003). Uncovering multiple axonal targeting pathways in hippocampal neurons. J Cell Biol 162, 1317-1328.
58. Yamazaki T, Selkoe DJ, Koo EH (1995). Trafficking of cell surface beta-Amyloid precursor protein: retrograde and transcytotic transport in cultured neurons. J Cell Biol 129, 431-442.
59. Yap CC, Wisco D, Kujala P, Lasiecka ZM, Cannon JT, Chang MC, Hirling H, Klumperman J, Winckler B (2008). The somatodendritic endosomal regulator NEEP21 facilitates axonal targeting of L1/NgCAM. J Cell Biol 180, 827-842.
60. Yuan SH, Martin J, Elia J, Flippin F, Paramban RI, Hefferan MP, Vidal JG, Mu Y, Killian RL, Israel M, et al. (2011). Cell-surface marker signatures for the isolation of neural stem cells, glia and neurons derived from human pluripotent stem cells. PLoS One 6, e17540.
61. Zhao J, Fu Y, Yasvoina M, Shao P, Hitt B, O'Connor T, Logan S, Maus E, Citron M, Berry R, et al. (2007). Site amyloid precursor protein cleaving enzyme 1 levels become elevated in neurons around amyloid plaques: implications for Alzheimer's disease pathogenesis. J Neurosci 27, 3639-3649.